Literature DB >> 2169572

Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.

S W Lamberts1, W H Bakker, J C Reubi, E P Krenning.   

Abstract

The presence of high numbers of somatostatin receptors seems to be the basis for the successful control by Sandostatin of hormonal hypersecretion by most growth hormone-secreting pituitary adenomas, endocrine pancreatic tumors, and carcinoids. In this report, we present preliminary data on in vivo somatostatin receptor imaging with a 123I-coupled somatostatin analog (204-090) in patients with these types of tumors.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2169572     DOI： 10.1016/0026-0495(90)90235-5

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


  11 in total

1.  Diagnosis and treatment of Cushing's syndrome. Cushing's syndrome: current clinical problems, symposium. Padova, October 19-20, 1990.

Authors: 
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

2.  Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.

Authors:  W Becker; J Marienhagen; R Scheubel; A Saptogino; W H Bakker; W A Breeman; F Wolf
Journal:  Eur J Nucl Med       Date:  1991

3.  The use of somatostatin receptor scintigraphy in the differential diagnosis of pancreatic duct cancers and islet cell tumors.

Authors:  C H van Eijck; S W Lamberts; L C Lemaire; H Jeekel; F T Bosman; J C Reubi; H A Bruining; E P Krenning
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

4.  Somatostatin receptor scintigraphy in patients with pituitary adenoma.

Authors:  A Rieger; N G Rainov; C Elfrich; M Klaua; H Meyer; C Lautenschläger; W Burkert; T Mende
Journal:  Neurosurg Rev       Date:  1997       Impact factor: 3.042

5.  Cloning and characterization of a fourth human somatostatin receptor.

Authors:  L Rohrer; F Raulf; C Bruns; R Buettner; F Hofstaedter; R Schüle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

6.  Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.

Authors:  U Dörr; U Räth; M L Sautter-Bihl; G Guzman; D Bach; H J Adrian; H Bihl
Journal:  Eur J Nucl Med       Date:  1993-05

Review 7.  Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.

Authors:  Marialuisa Appetecchia; Roberto Baldelli
Journal:  J Exp Clin Cancer Res       Date:  2010-03-02

8.  Avid thallium-201 uptake in hepatic carcinoid metastases.

Authors:  R Nour; R J Quinn; D L Morris; S P Butler
Journal:  Eur J Nucl Med       Date:  1993-09

9.  Preoperative detection of insulinomas: two case reports.

Authors:  Mesut Ozkaya; Mehmet Fatih Yuzbasioglu; Irfan Koruk; Erman Cakal; Mustafa Sahin; Basak Cakal
Journal:  Cases J       Date:  2008-11-29

Review 10.  Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.

Authors:  Roberto Baldelli; A Barnabei; L Rizza; A M Isidori; F Rota; P Di Giacinto; A Paoloni; F Torino; S M Corsello; A Lenzi; M Appetecchia
Journal:  Front Endocrinol (Lausanne)       Date:  2014-02-07       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.